134 related articles for article (PubMed ID: 11164176)
21. Benign prostatic hyperplasia and normal prostate aging: differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels.
Bonnet P; Reiter E; Bruyninx M; Sente B; Dombrowicz D; de Leval J; Closset J; Hennen G
J Clin Endocrinol Metab; 1993 Nov; 77(5):1203-8. PubMed ID: 7521342
[TBL] [Abstract][Full Text] [Related]
22. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
[TBL] [Abstract][Full Text] [Related]
23. Elastin gene expression in benign prostatic hyperplasia.
Djavan B; Lin V; Seitz C; Kramer G; Kaplan P; Richier J; Marberger M; McConnell JD
Prostate; 1999 Sep; 40(4):242-7. PubMed ID: 10420152
[TBL] [Abstract][Full Text] [Related]
24. Prostatic stromal cells derived from benign prostatic hyperplasia specimens possess stem cell like property.
Lin VK; Wang SY; Vazquez DV; C Xu C; Zhang S; Tang L
Prostate; 2007 Sep; 67(12):1265-76. PubMed ID: 17597114
[TBL] [Abstract][Full Text] [Related]
25. Intermittent β-adrenergic blockade downregulates the gene expression of β-myosin heavy chain in the mouse heart.
Maccari S; Pace V; Barbagallo F; Stati T; Ambrosio C; Grò MC; Molinari P; Vezzi V; Catalano L; Matarrese P; Patrizio M; Rizzi R; Marano G
Eur J Pharmacol; 2020 Sep; 882():173287. PubMed ID: 32585157
[TBL] [Abstract][Full Text] [Related]
26. Regulation of proliferation and differentiation of prostatic stromal cells by oestradiol through prostatic epithelial cells in a paracrine manner.
Wu Q; Shi J; Chen L; Wang CY; Park I; Lee C; Zhang J
BJU Int; 2008 Feb; 101(4):497-502. PubMed ID: 18190643
[TBL] [Abstract][Full Text] [Related]
27. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
[TBL] [Abstract][Full Text] [Related]
28. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
[TBL] [Abstract][Full Text] [Related]
29. Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?
Eri LM; Svindland A
Urology; 2000 Aug; 56(2):261-5. PubMed ID: 10925090
[TBL] [Abstract][Full Text] [Related]
30. Differential gene expression of transforming growth factors alpha and beta, epidermal growth factor, keratinocyte growth factor, and their receptors in fetal and adult human prostatic tissues and cancer cell lines.
Dahiya R; Lee C; Haughney PC; Chui R; Ho R; Deng G
Urology; 1996 Dec; 48(6):963-70. PubMed ID: 8973690
[TBL] [Abstract][Full Text] [Related]
31. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
32. [Expression of corticotropin releasing factor receptor 2 (CRFR2) in the human prostate. A new potential target for medical therapy of benign prostatic hyperplasia].
Tezval H; Merseburger AS; Seidler M; Serth J; Kuczyk MA; Oelke M
Urologe A; 2008 Sep; 47(9):1079-80, 1082-4. PubMed ID: 18670748
[TBL] [Abstract][Full Text] [Related]
33. Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.
Zhao H; Ramos CF; Brooks JD; Peehl DM
J Cell Physiol; 2007 Jan; 210(1):111-21. PubMed ID: 17044071
[TBL] [Abstract][Full Text] [Related]
34. Finasteride upregulates expression of androgen receptor in hyperplastic prostate and LNCaP cells: implications for chemoprevention of prostate cancer.
Hsieh JT; Chen SC; Yu HJ; Chang HC
Prostate; 2011 Jul; 71(10):1115-21. PubMed ID: 21557276
[TBL] [Abstract][Full Text] [Related]
35. Correlation between androgen receptor expression and FGF8 mRNA levels in patients with prostate cancer and benign prostatic hypertrophy.
Wang Q; Stamp GW; Powell S; Abel P; Laniado M; Mahony C; Lalani EN; Waxman J
J Clin Pathol; 1999 Jan; 52(1):29-34. PubMed ID: 10343609
[TBL] [Abstract][Full Text] [Related]
36. Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate.
Dillner K; Kindblom J; Flores-Morales A; Shao R; Törnell J; Norstedt G; Wennbo H
Endocrinology; 2003 Nov; 144(11):4955-66. PubMed ID: 12960074
[TBL] [Abstract][Full Text] [Related]
37. Increased incidence of luteinizing hormone-releasing hormone receptor gene messenger RNA expression in hormone-refractory human prostate cancers.
Straub B; Müller M; Krause H; Schrader M; Goessl C; Heicappell R; Miller K
Clin Cancer Res; 2001 Aug; 7(8):2340-3. PubMed ID: 11489810
[TBL] [Abstract][Full Text] [Related]
38. Expression of c-MET/HGF receptor mRNA and protein in human non-malignant and malignant prostate tissues.
Tsuka H; Mori H; Li B; Kanamaru H; Matsukawa S; Okada K
Int J Oncol; 1998 Nov; 13(5):927-34. PubMed ID: 9772281
[TBL] [Abstract][Full Text] [Related]
39. Real-time quantitative reverse transcriptase-polymerase chain reaction for luteinizing hormone-releasing hormone receptor gene mRNA expression in human prostate cancer.
Straub B; Müller M; Krause H; Schrader M; Miller K
Urology; 2003 Jul; 62(1):172-6. PubMed ID: 12837461
[TBL] [Abstract][Full Text] [Related]
40. Combining growth hormone-releasing hormone antagonist with luteinizing hormone-releasing hormone antagonist greatly augments benign prostatic hyperplasia shrinkage.
Rick FG; Szalontay L; Schally AV; Block NL; Nadji M; Szepeshazi K; Vidaurre I; Zarandi M; Kovacs M; Rekasi Z
J Urol; 2012 Apr; 187(4):1498-504. PubMed ID: 22341819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
